SodaSlim Ingredients: All Five Actives And What Each One Is For

The most researched compound in this formula and the only one that does anything within the hour. It raises alertness by blocking adenosine, and it raises resting energy expenditure by a modest amount that is easy to measure and easy to over-sell. A dose-response meta-analysis of thirteen randomised trials in 606 people reported that doubling caffeine intake was associated with roughly a fifth more reduction in weight, body mass index and fat mass.

The trials that measured energy expenditure directly used real amounts. One double-blind crossover study gave 5 mg per kilogram of body weight a day, which for an 80 kg adult is 400 mg: about four strong cups of coffee. The review behind the commonly quoted 400 mg a day figure for healthy adults treats that as a total across every source, which is the arithmetic an unstated capsule makes impossible.

Tolerance matters here and the label does not mention it. A habitual coffee drinker starting this capsule is adding to an already adapted system, and the thermogenic response is smaller in that group than in somebody who drinks none.

Coffee beans that have not been roasted keep far more of their chlorogenic acid, which is the compound this extract is standardised for and the reason it is in the bottle. The proposed mechanism is slower glucose absorption from a meal, with a secondary story about fat oxidation.

The 2023 systematic review and meta-analysis pooled three randomised trials, 103 people in total, of green coffee extract carrying at least 500 mg of chlorogenic acid a day. It found a mean weight reduction of 1.3 kg with no heterogeneity between the studies and no sign of publication bias. That is a modest, honest result on a small base, and it is attached to a number. A separate eight-week trial gave 400 mg a day of the extract alongside an energy-restricted diet.

This ingredient also carries the cautionary tale of the whole category. The 2012 crossover study that made green coffee famous reported 8 kg of loss on 16 people at 700 and 1,050 mg, went on daytime television, and was retracted by its journal two years later. NCBI still returns it with the publication type Retracted Publication. If you have heard that green coffee produces dramatic results, that is the study you heard about.

What survives the retraction is smaller and more believable: a review of the blood-pressure claim and a meta-analysis of cardiovascular risk markers both find measurable but modest effects, and the mouse work the ingredient story started from remains mouse work.

This is the ingredient this desk cannot support, and saying so is the only honest way to write this panel. A search of the published literature for raspberry ketone and human body weight returns reviews, cell work and animal studies. It does not return a randomised controlled trial of the compound in people, because there is not one.

What exists is suggestive and it is all pre-clinical. A 2017 study in 3T3-L1 cells and ovariectomised rats found reduced lipid accumulation through an autophagy mechanism. A 2022 review and a 2021 pharmacological review both describe plausible metabolic activity and both note the absence of clinical data.

The most useful study is the one that failed. A mouse trial on a high-fat diet compared raspberry ketone at 0.25 and 1.74 per cent of the diet by weight against a pair-fed group eating the same amount of food. The ketone did not reduce adiposity beyond the effect of the reduced food intake it caused. In other words, what looked like fat loss was the animals eating less.

Its presence in the capsule is not a reason to avoid the bottle. It is a reason not to buy the bottle for this ingredient, and a reason to treat any page that leads with it as marketing.

The source of hydroxycitric acid, which competitively inhibits ATP-citrate lyase, an enzyme involved in turning carbohydrate into fat. It is also sold for satiety. The mechanism is real biochemistry; the question is whether it produces anything measurable in a person.

The largest and best-known trial put 135 overweight adults on a high-fibre, low-energy diet for twelve weeks and gave half of them 1,500 mg of hydroxycitric acid a day and half a placebo. Weight came off in both arms. Statistically the two arms were indistinguishable, on fat mass as well as on weight.

A 2020 dose-response meta-analysis of eight trials in 530 people found a pooled reduction of 1.34 kg, which is a positive result and a small one. The main safety overview of the standardised extract was written by researchers with a commercial interest in it, which is worth knowing when reading its conclusions.

Garcinia is also the ingredient most often named in the liver-injury literature for this category. A systematic review of herb-induced liver injury and a review of supplement-related liver injury both discuss weight-loss products containing it. The cases are rare and the amounts involved are generally far above anything a once-daily capsule would carry, which is the sort of reassurance a printed figure would let this desk give properly.

Concentrated catechins, chiefly epigallocatechin gallate, usually with some of the leaf's own caffeine alongside. The proposal is that catechins and caffeine together raise energy expenditure by more than caffeine alone.

A meta-analysis of catechin and caffeine mixtures found a mean reduction of 1.31 kg, with the effect blunted in people already taking more than 300 mg of caffeine a day. That last detail is the one worth carrying away from this whole page: the two stimulant ingredients in this bottle compete with the coffee already in your morning.

The Cochrane review is less generous. Pooling six trials conducted outside Japan in 532 people, it found a mean difference of 0.04 kg and concluded that green tea preparations produce a small, statistically non-significant loss that is unlikely to be clinically important. A 2024 meta-analysis looked at whether catechins add anything to exercise training.

Concentrated extract is also where this formula's only real safety literature sits. A systematic safety review proposed an intake level of 338 mg of EGCG a day taken as a bolus, with an observed safe level of 704 mg, and a randomised trial at 843 mg a day for six to nine months examined liver enzymes directly. An analysis of what green tea supplements actually contain found wide variation between label claim and measured content across commercial products, which is a general finding about the category rather than about this bottle.